LYV
CTIC

Live Your Vision’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Live Your Vision’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$0 Hold
6
– – ﹤0.01% 297
2018
Q4 		$0 Hold
6
– – ﹤0.01% 300
2018
Q3 		$0 Hold
6
– – ﹤0.01% 343
2018
Q2 		$0 Hold
6
– – ﹤0.01% 347
2018
Q1 		$0 Hold
6
– – ﹤0.01% 295
2017
Q4 		$0 Hold
6
– – ﹤0.01% 302
2017
Q3 		$0 Hold
6
– – ﹤0.01% 327
2017
Q2 		$0 Hold
6
– – ﹤0.01% 331
2017
Q1 		$0 Sell
6
-1
-14% -$5 ﹤0.01% 331
2016
Q4 		$0 Hold
7
– – ﹤0.01% 342
2016
Q3 		$0 Buy
+7
New +$25 ﹤0.01% 316

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Live Your Vision's CTIC Position: Q1 2019 in Review

Live Your Vision held its CTI BioPharma Corp. (DE) Common Stock (CTIC) position steady in Q1 2019 at 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Live Your Vision first reported a position in CTIC in Q3 2016 and has held it in 11 quarters since. 67 funds tracked by Wall St. Rank hold CTIC as of Q1 2019.

  • Live Your Vision held 6 shares of CTI BioPharma Corp. (DE) Common Stock worth $0 as of Q1 2019.
  • Live Your Vision left its CTI BioPharma Corp. (DE) Common Stock share count unchanged in Q1 2019.
  • CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of Live Your Vision's portfolio in Q1 2019, its #297 holding.
  • Live Your Vision first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2016 and has held it in 11 quarters since.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2019.

Based on Live Your Vision's 13F filing for Q1 2019, filed 25 Apr 2019.